Not logged in.png)
Share.png)
SaveA phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET
Hayashi, Fumiko; Matsuo, Midori; Takemoto, Shinnosuke; Ogata, Ryosuke; Umeyama, Yasuhiro; Nakatomi, Katsumi; Ikeda, Takaya; Sugasaki, Nanae; Doi, Seiji; Kitazaki, Takeshi; Akagi, Kazumasa; Tomono, Hiromi; Honda, Noritaka; Dotsu, Yosuke; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Fukuda, Minoru; Soda, Hiroshi; Mukae, Hiroshi Share Save Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)Takemoto, Shinnosuke; Fukuda, Minoru; Ogata, Ryosuke; Senju, Hiroaki; Sugasaki, Nanae; Nakatomi, Katsumi; Tomono, Hiromi; Suyama, Takayuki; Sasaki, Eisuke; Matsuo, Midori; Akagi, Kazumasa; Hayashi, Fumiko; Dotsu, Yosuke; Ono, Sawana; Honda, Noritaka; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Ikeda, Takaya; Nagashima, Seiji; Soda, Hiroshi; Kinoshita, Akitoshi; Mukae, Hiroshi Share Save A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Ito, Kentaro; Tsuchiya-Kawano, Yuko; Tanaka, Kentaro; Harada, Taishi; Nakatani, Yuki; Miura, Satoru; Yokoyama, Toshihide; Nakamura, Tomomi; Izumi, Miiru; Nakamura, Atsushi; Ikeda, Satoshi; Takayama, Koichi; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji Share Save Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targetsShimada, Midori; Taniguchi, Hirokazu; Yamaguchi, Hiroyuki; Gyotoku, Hiroshi; Sasaki, Daisuke; Kaku, Norihito; Senju, Chikako; Senju, Hiroaki; Imamura, Erika; Takemoto, Shinnosuke; Yamamoto, Kazuko; Sakamoto, Noriho; Obase, Yasushi; Tsuchiya, Tomoshi; Fukuda, Minoru; Soda, Hiroshi; Ashizawa, Kazuto; Fukuoka, Junya; Nagayasu, Takeshi; Yanagihara, Katsunori; Mukae, Hiroshi Share Save Share Save Share Save Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating FactorDotsu, Yosuke; Yamaguchi, Hiroyuki; Fukuda, Minoru; Suyama, Takayuki; Honda, Noritaka; Umeyama, Yasuhiro; Taniguchi, Hirokazu; Gyotoku, Hiroshi; Takemoto, Shinnosuke; Tagawa, Ryuta; Ogata, Ryosuke; Tomono, Hiromi; Shimada, Midori; Senju, Hiroaki; Nakatomi, Katsumi; Nagashima, Seiji; Soda, Hiroshi; Ikeda, Hiroaki; Ashizawa, Kazuto; Mukae, Hiroshi Share Save A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancerSakai, Yumiko; Kurose, Koji; Sakaeda, Kanako; Abo, Hirotaka; Atarashi, Yusuke; Ide, Nobuyuki; Sato, Toshiyuki; Kanda, Eiichiro; Fukuda, Minoru; Oga, Toru; Noda, Kenta; Oka, Mikio Share Save A reevaluation of adjuvant chemotherapy for colon cancer in our departmentKobayashi, Kazuma; Fujita, Takuro; Sato, Ayaka; Ito, Shinichiro; Inoue, Yusuke; Okada, Satomi; Kuba, Sayaka; Morita, Michi; Kobayashi, Shinichiro; Maruya, Yasuhiro; Fukumoto, Masayuki; Kosaka, Taiichiro; Soyama, Akihiko; Fukuda, Minoru; Honda, Takuya; Adachi, Tomohiko; Hidaka, Masaaki; Kanetaka, Kengo; Eguchi, Susumu Share Save Osimertinib for RT-naive CNS metastasis of EGFRm NSCLC: pll OCEAN study (LOGIK 1603/WJOG 9116L), part of T790M cohortChibana, Kenji; Yamaguchi, Hiroyuki; Wakuda, Kazushige; Fukuda, Minoru; Kenmotsu, Hirotsugu; Yoshimura, Kenichi; Inoue, Koji; Miura, Satoru; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji Share Save A review of adjuvant chemotherapy for rectal cancer in our department, focusing on one-year administration of S-1Kobayashi, Kazuma; Sato, Ayaka; Fujita, Takuro; Ito, Shinichiro; Inoue, Yusuke; Okada, Satomi; Kuba, Sayaka; Morita, Michi; Kobayashi, Shinichiro; Maruya, Yasuhiro; Fukumoto, Masayuki; Kosaka, Taiichiro; Soyama, Akihiko; Fukuda, Minoru; Honda, Takuya; Adachi, Tomohiko; Hidaka, Masaaki; Kanetaka, Kengo; Eguchi, Susumu Share Save Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumoursNonaka, Motohiro; Suzuki-Anekoji, Misa; Nakayama, Jun; Mabashi-Asazuma, Hideaki; Jarvis, Donald L.; Yeh, Jiunn-Chern; Yamasaki, Kazuhiko; Akama, Tomoya O.; Huang, Chun-Teng; Campos, Alexandre Rosa; Nagaoka, Masato; Sasai, Toshio; Kimura-Takagi, Itsuko; Suwa, Yoichi; Yaegashi, Takashi; Shibata, Toshiaki K.; Sugihara, Kazuhiro; Nishizawa-Harada, Chizuko; Fukuda, Minoru; Fukuda, Michiko N. Share Save Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous TreatmentNakao, Akira; Hiranuma, Osamu; Uchino, Junji; Sakaguchi, Chikara; Araya, Tomoyuki; Hiraoka, Noriya; Ishizuka, Tamotsu; Takeda, Takayuki; Kawasaki, Masayuki; Goto, Yasuhiro; Imai, Hisao; Hattori, Noboru; Nakatomi, Keita; Uramoto, Hidetaka; Uryu, Kiyoaki; Fukuda, Minoru; Uchida, Yasuki; Yokoyama, Toshihide; Akai, Masaya; Mio, Tadashi; Nagashima, Seiji; Chihara, Yusuke; Tamiya, Nobuyo; Kaneko, Yoshiko; Mouri, Takako; Yamada, Tadaaki; Yoshimura, Kenichi; Fujita, Masaki; Takayama, Koichi Share Save A phase II study of Osimertinib for patients with radiotherapy-naive CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Takeshita, Masafumi; Suetsugu, Takayuki; Kirita, Keisuke; Ebi, Noriyuki; Hataji, Osamu; Miura, Satoru; Chibana, Kenji; Okamoto, Isamu; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji Share Save Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis ScoringGyotoku, Hiroshi; Yamaguchi, Hiroyuki; Ishimoto, Hiroshi; Sato, Shuntaro; Taniguchi, Hirokazu; Senju, Hiroaki; Kakugawa, Tomoyuki; Nakatomi, Katsumi; Sakamoto, Noriho; Fukuda, Minoru; Obase, Yasushi; Soda, Hiroshi; Ashizawa, Kazuto; Mukae, Hiroshi Share Save AXL confers intrinsic resistance to osimertinib and the emergence of tolerant cellsTaniguchi, Hirokazu; Yamada, Tadaaki; Wang, Rong; Tanimura, Keiko; Nishiyama, Akihiro; Tanimoto, Azusa; Adachi, Yuta; Takeuchi, Shinji; Yamaguchi, Hiroyuki; Fukuda, Minoru; Takayama, Koichi; Mukae, Hiroshi; Yano, Seiji Share Save Genetic analysis of thymoma and thymic carcinomaYamaguchi, Hiroyuki; Gyotoku, Hiroshi; Taniguchi, Hirokazu; Sasaki, Daisuke; Shimada, Midori; Dotsu, Yosuke; Senju, Hiroaki; Kaku, Norihito; Ikeda, Takaya; Fukuda, Minoru; Yanagihara, Katsunori; Mukae, Hiroshi Share Save Effect of IL-18 on the expansion and phenotype of human natural killer cellsSenju, Hiroaki; Kumagai, Asuka; Nakamura, Yoichi; Takemoto, Shinnosuke; Fukuda, Masaaki; Gyotoku, Hiroshi; Nakatomi, Katsumi; Fukuda, Minoru; Mukae, Hiroshi; Tanaka, Yoshimasa Share Save Surface LAMP-2 Is an Endocytic Receptor That Diverts Antigen Internalized by Human Dendritic Cells into Highly Immunogenic ExosomesLeone, Dario Armando; Peschel, Andrea; Brown, Markus; Schachner, Helga; Ball, Miriam J.; Gyuraszova, Marianna; Salzer-Muhar, Ulrike; Fukuda, Minoru; Vizzardelli, Caterina; Bohle, Barbara; Rees, Andrew J.; Kain, Renate Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}